Literature DB >> 1570328

Enzymatic defect in "X-linked" sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency.

P D Cotter1, M Baumann, D F Bishop.   

Abstract

Recently, the human gene encoding erythroid-specific delta-aminolevulinate synthase was localized to the chromosomal region Xp21-Xq21, identifying this gene as the logical candidate for the enzymatic defect causing "X-linked" sideroblastic anemia. To investigate this hypothesis, the 11 exonic coding regions of the delta-aminolevulinate synthase gene were amplified and sequenced from a 30-year-old Chinese male with a pyridoxine-responsive form of X-linked sideroblastic anemia. A single T----A transition was found in codon 471 in a highly conserved region of exon 9, resulting in an Ile----Asn substitution. This mutation interrupted contiguous hydrophobic residues and was predicted to transform a region of beta-sheet structure to a random-coil structure. Prokaryotic expression of the normal and mutant cDNAs revealed that the mutant construct expressed low levels of enzymatic activity that required higher concentrations of pyridoxal 5'-phosphate to achieve maximal activation than did the normal enzyme. The amino acid substitution occurred in the exon containing the putative pyridoxal 5'-phosphate binding site and may account for the reduced ability of the cofactor to catalyze the formation of delta-aminolevulinic acid.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1570328      PMCID: PMC525625          DOI: 10.1073/pnas.89.9.4028

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

2.  An immunochemical study of delta-aminolevulinate synthase and delta-aminolevulinate dehydratase in liver and erythroid cells of rat.

Authors:  M Yamamoto; H Fujita; N Watanabe; N Hayashi; G Kikuchi
Journal:  Arch Biochem Biophys       Date:  1986-02-15       Impact factor: 4.013

3.  Sequence of human 5-aminolevulinate synthase cDNA.

Authors:  M J Bawden; I A Borthwick; H M Healy; C P Morris; B K May; W H Elliott
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

Review 4.  Heme synthesis in sideroblastic anaemias.

Authors:  A Pasanen; R Tenhunen
Journal:  Scand J Haematol Suppl       Date:  1986

5.  Isolation of recombinant cDNAs encoding chicken erythroid delta-aminolevulinate synthase.

Authors:  M Yamamoto; N S Yew; M Federspiel; J B Dodgson; N Hayashi; J D Engel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Complete nucleotide sequence of hepatic 5-aminolaevulinate synthase precursor.

Authors:  I A Borthwick; G Srivastava; A R Day; B A Pirola; M A Snoswell; B K May; W H Elliott
Journal:  Eur J Biochem       Date:  1985-08-01

Review 7.  Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis.

Authors:  B K May; C R Bhasker; M J Bawden; T C Cox
Journal:  Mol Biol Med       Date:  1990-10

8.  The nucleotide sequence of the HEM1 gene and evidence for a precursor form of the mitochondrial 5-aminolevulinate synthase in Saccharomyces cerevisiae.

Authors:  D Urban-Grimal; C Volland; T Garnier; P Dehoux; R Labbe-Bois
Journal:  Eur J Biochem       Date:  1986-05-02

9.  Regulation of production of embryonic chick liver delta-aminolevulinate synthase: effects of testosterone and of hemin on the mRNA of the enzyme.

Authors:  P D Drew; I Z Ades
Journal:  Biochem Biophys Res Commun       Date:  1986-10-15       Impact factor: 3.575

10.  Structure of the Bradyrhizobium japonicum gene hemA encoding 5-aminolevulinic acid synthase.

Authors:  C R McClung; J E Somerville; M L Guerinot; B K Chelm
Journal:  Gene       Date:  1987       Impact factor: 3.688

View more
  50 in total

Review 1.  Mammalian iron metabolism and its control by iron regulatory proteins.

Authors:  Cole P Anderson; Macy Shen; Richard S Eisenstein; Elizabeth A Leibold
Journal:  Biochim Biophys Acta       Date:  2012-05-17

2.  Mitochondrial disorders of the nuclear genome.

Authors:  C Angelini; L Bello; M Spinazzi; C Ferrati
Journal:  Acta Myol       Date:  2009-07

Review 3.  5-Aminolevulinate synthase and the first step of heme biosynthesis.

Authors:  G C Ferreira; J Gong
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

Review 4.  Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia.

Authors:  S S Bottomley; B K May; T C Cox; P D Cotter; D F Bishop
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

5.  [Hereditary metabolic diseases with cutaneous manifestations : An update].

Authors:  J Frank; P Poblete-Gutiérrez
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

Review 6.  Iron metabolism in erythroid cells and patients with congenital sideroblastic anemia.

Authors:  Kazumichi Furuyama; Kiriko Kaneko
Journal:  Int J Hematol       Date:  2017-11-14       Impact factor: 2.490

7.  Iron and copper in mitochondrial diseases.

Authors:  Wenjing Xu; Tomasa Barrientos; Nancy C Andrews
Journal:  Cell Metab       Date:  2013-03-05       Impact factor: 27.287

Review 8.  Erythroid heme biosynthesis and its disorders.

Authors:  Harry A Dailey; Peter N Meissner
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

9.  Expression of the Rhodobacter sphaeroides hemA and hemT genes, encoding two 5-aminolevulinic acid synthase isozymes.

Authors:  E L Neidle; S Kaplan
Journal:  J Bacteriol       Date:  1993-04       Impact factor: 3.490

10.  X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the β-subunit of succinyl-CoA synthetase (SUCLA2).

Authors:  David F Bishop; Vassili Tchaikovskii; A Victor Hoffbrand; Marie E Fraser; Steven Margolis
Journal:  J Biol Chem       Date:  2012-06-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.